BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37203462)

  • 21. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
    de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
    Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Value of pH Impedance Monitoring While on Twice-Daily Proton Pump Inhibitor Therapy to Identify Need for Escalation of Reflux Management.
    Gyawali CP; Tutuian R; Zerbib F; Rogers BD; Frazzoni M; Roman S; Savarino E; de Bortoli N; Vela MF; Sifrim D
    Gastroenterology; 2021 Nov; 161(5):1412-1422. PubMed ID: 34270955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of improvement of impaired chemical clearance characterizes PPI-refractory reflux-related heartburn.
    Frazzoni M; Frazzoni L; Tolone S; De Bortoli N; Savarino V; Savarino E
    Am J Gastroenterol; 2018 May; 113(5):670-676. PubMed ID: 29681623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conventional and simple methods of measuring esophageal nocturnal baseline impedance show excellent agreement.
    Park JS; Van der Wall H; Falk GL
    J Dig Dis; 2021 Jul; 22(7):419-424. PubMed ID: 34042298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of Distal Mean Nocturnal Baseline Impedance in Differentiating GERD Phenotypes.
    Sararu R; Peagu R; Fierbinteanu-Braticevici C
    J Gastrointestin Liver Dis; 2023 Sep; 32(3):291-297. PubMed ID: 37774210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Artificial intelligence automates and augments baseline impedance measurements from pH-impedance studies in gastroesophageal reflux disease.
    Rogers B; Samanta S; Ghobadi K; Patel A; Savarino E; Roman S; Sifrim D; Gyawali CP
    J Gastroenterol; 2021 Jan; 56(1):34-41. PubMed ID: 33151406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of aging and obesity on esophageal mucosal integrity as measured by baseline impedance.
    Voulgaris T; Hoshino S; Sifrim D; Yazaki E
    Neurogastroenterol Motil; 2023 Sep; 35(9):e14626. PubMed ID: 37332225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between baseline impedance values and response proton pump inhibitors in patients with heartburn.
    de Bortoli N; Martinucci I; Savarino E; Tutuian R; Frazzoni M; Piaggi P; Bertani L; Furnari M; Franchi R; Russo S; Bellini M; Savarino V; Marchi S
    Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1082-8.e1. PubMed ID: 25499991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mean nocturnal baseline impedance: Influencing factors and diagnostic value in gastroesophageal reflux disease.
    Wang N; Guo ZH; Wu YH; Zhang C
    Technol Health Care; 2023; 31(5):1875-1886. PubMed ID: 36970927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mean Nocturnal Baseline Impedance and Post-reflux Swallow-induced Peristaltic Wave Index Could Identify Gastroesophageal Reflux Disease but pH-Impedance Metrics Alone Might Not Correlate With Proton Pump Inhibitor Response in Chinese Patients With Typical Reflux Symptoms.
    Wang D; Duan C; Zhang X; Xu J; Hou X; Xiang X
    J Neurogastroenterol Motil; 2022 Oct; 28(4):580-588. PubMed ID: 36250365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of Reflux in the Pathogenesis of Eosinophilic Esophagitis: Comprehensive Appraisal With Off- and On PPI Impedance-pH Monitoring.
    Frazzoni M; Penagini R; Frazzoni L; de Bortoli N; Mauro A; Tolone S; Bertani H; Marsico M; Marocchi M; Marchi S; Conigliaro R; Savarino E
    Am J Gastroenterol; 2019 Oct; 114(10):1606-1613. PubMed ID: 31449157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastroesophageal Reflux Disease Diagnosis by New Consensus in Clinical Practice: The Additional Value of Mean Basal Impedance.
    Gomes AC; Sousa M; Lopes R; Afecto E; Correia J; Freitas T; Carvalho J
    Dig Dis; 2022; 40(3):261-265. PubMed ID: 34348287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Esophageal intraluminal baseline impedance differentiates gastroesophageal reflux disease from functional heartburn.
    Kandulski A; Weigt J; Caro C; Jechorek D; Wex T; Malfertheiner P
    Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1075-81. PubMed ID: 25496815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between reflux burden, peristaltic function, and mucosal integrity in GERD patients.
    Ribolsi M; Gyawali CP; Savarino E; Rogers B; Rengarajan A; Della Coletta M; Ghisa M; Cicala M
    Neurogastroenterol Motil; 2020 Mar; 32(3):e13752. PubMed ID: 31670453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Refractory gastroesophageal reflux disease as diagnosed by impedance-pH monitoring can be cured by laparoscopic fundoplication.
    Frazzoni M; Piccoli M; Conigliaro R; Manta R; Frazzoni L; Melotti G
    Surg Endosc; 2013 Aug; 27(8):2940-6. PubMed ID: 23436097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Results From Up-Front Esophageal Testing Predict Proton Pump Inhibitor Response in Patients With Chronic Cough.
    Ribolsi M; Luca Guarino MP; Balestrieri P; Altomare A; Tullio A; Petitti T; Cicala M
    Am J Gastroenterol; 2021 Nov; 116(11):2199-2206. PubMed ID: 34287222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychosocial Distress and Quality of Life Impairment Are Associated With Symptom Severity in PPI Non-Responders With Normal Impedance-pH Profiles.
    Yadlapati R; Tye M; Keefer L; Kahrilas PJ; Pandolfino JE
    Am J Gastroenterol; 2018 Jan; 113(1):31-38. PubMed ID: 28895583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of endoscopic fundoplication and proton pump inhibitors on baseline impedance and heartburn severity in GERD patients.
    Rinsma NF; Farré R; Bouvy ND; Masclee AA; Conchillo JM
    Neurogastroenterol Motil; 2015 Feb; 27(2):220-8. PubMed ID: 25348594
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Esophageal acid exposure decreases intraluminal baseline impedance levels.
    Kessing BF; Bredenoord AJ; Weijenborg PW; Hemmink GJ; Loots CM; Smout AJ
    Am J Gastroenterol; 2011 Dec; 106(12):2093-7. PubMed ID: 21844921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Positive predictors for gastroesophageal reflux disease and the therapeutic response to proton-pump inhibitors.
    Becker V; Grotz S; Schlag C; Nennstiel S; Beitz A; Haller B; Schmid RM; Meining A; Bajbouj M
    World J Gastroenterol; 2014 Apr; 20(14):4017-24. PubMed ID: 24744591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.